States / U.S. Congress / HR 2821
HR 2821 Passed First Chamber
FDA Modernization Act 3.0
Introduced
In Committee
Floor
Crossed Over
Passed
Enacted
Jul 21, 2026 · Senate
Received in the Senate.
Jul 20, 2026 · House
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H4639)
Jul 20, 2026 · House
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H4639)
Jul 20, 2026 · House
DEBATE - The House proceeded with forty minutes of debate on H.R. 2821.
Jul 20, 2026 · House
Considered under suspension of the rules. (consideration: CR H4639-4640)
Jul 20, 2026 · House
Mr. Guthrie moved to suspend the rules and pass the bill.
Jul 20, 2026 · House
Motion to reconsider laid on the table Agreed to without objection.
Jun 18, 2026 · House
Placed on the Union Calendar, Calendar No. 614.
Jun 18, 2026 · House
Reported by the Committee on Energy and Commerce. H. Rept. 119-706.
May 21, 2026 · House
Ordered to be Reported by the Yeas and Nays: 44 - 0.
May 21, 2026 · House
Committee Consideration and Mark-up Session Held
May 13, 2026 · House
Forwarded by Subcommittee to Full Committee by Voice Vote.
May 13, 2026 · House
Subcommittee Consideration and Mark-up Session Held
Apr 10, 2026 · House
Referred to the Subcommittee on Health.
Apr 10, 2025 · House
Referred to the House Committee on Energy and Commerce.
Apr 10, 2025 · House
Introduced in House